-
1
-
-
0037126649
-
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States
-
and the Acute Liver Failure Study Group
-
Ostapowicz GA, Fontana RJ, Schiodt FV et al. and the Acute Liver Failure Study Group. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 945-54.
-
(2002)
Ann Intern Med
, vol.137
, pp. 945-954
-
-
Ostapowicz, G.A.1
Fontana, R.J.2
Schiodt, F.V.3
-
2
-
-
58049126949
-
-
Testimony of Parivash Nourjah, PhD. Available from URL
-
Proceedings of the FDA NDAC meeting September 19, 2002. Testimony of Parivash Nourjah, PhD. Available from URL: http://www.fda.gov/ohrms/ dockets/ac/cder02.htm#NonprescriptionDrugs
-
Proceedings of the FDA NDAC Meeting September 19, 2002
-
-
-
3
-
-
0041317597
-
Acute liver failure in the United States
-
Lee WM. Acute liver failure in the United States. Semin Liver Dis 2003; 23: 217-26.
-
(2003)
Semin Liver Dis
, vol.23
, pp. 217-226
-
-
Lee, W.M.1
-
4
-
-
0014029833
-
Liver damage and impaired glucose tolerance after paracetamol overdose
-
Thompson JS, Prescott LF. Liver damage and impaired glucose tolerance after paracetamol overdose. BMJ 1966; 2: 506-07.
-
(1966)
BMJ
, vol.2
, pp. 506-507
-
-
Thompson, J.S.1
Prescott, L.F.2
-
5
-
-
0015231479
-
Acetaminophen-induced hepatic necrosis and renal failure
-
Boyer TD, Rouff SL. Acetaminophen-induced hepatic necrosis and renal failure. JAMA 1971; 218: 440-1.
-
(1971)
JAMA
, vol.218
, pp. 440-441
-
-
Boyer, T.D.1
Rouff, S.L.2
-
6
-
-
20844444779
-
Idiosyncratic drug hepatotoxicity
-
Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 2005; 4: 489-99.
-
(2005)
Nat Rev Drug Discov
, vol.4
, pp. 489-499
-
-
Kaplowitz, N.1
-
7
-
-
0029083319
-
Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure
-
Zimmerman HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology 1995; 22: 767-73.
-
(1995)
Hepatology
, vol.22
, pp. 767-773
-
-
Zimmerman, H.J.1
Maddrey, W.C.2
-
8
-
-
0025124764
-
Acetaminophen hepatotoxicity in the alcoholic
-
Wootton FT, Lee WM. Acetaminophen hepatotoxicity in the alcoholic. South Med J 1990; 83: 1047-49.
-
(1990)
South Med J
, vol.83
, pp. 1047-1049
-
-
Wootton, F.T.1
Lee, W.M.2
-
9
-
-
0028149489
-
Association of acetaminophen hepatotoxicity with fasting and ethanol use
-
Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272: 1845-50.
-
(1994)
JAMA
, vol.272
, pp. 1845-1850
-
-
Whitcomb, D.C.1
Block, G.D.2
-
10
-
-
0030639567
-
Acetaminophen-induced hepatotoxicity: Predisposing factors and treatments
-
Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: Predisposing factors and treatments. Adv Intern Med 1997; 42: 453-83.
-
(1997)
Adv Intern Med
, vol.42
, pp. 453-483
-
-
Makin, A.J.1
Williams, R.2
-
11
-
-
32644474169
-
Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study
-
and the ALFSG
-
Larson AM, Fontana RJ, Davern TJ et al. and the ALFSG. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology 2005; 42: 1367-72.
-
(2005)
Hepatology
, vol.42
, pp. 1367-1372
-
-
Larson, A.M.1
Fontana, R.J.2
Davern, T.J.3
-
13
-
-
0033058105
-
Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: An explanation for high acetaminophen dos age in humans without hepatic injury
-
Shayiq RM, Roberts DW, Rothstein K et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: An explanation for high acetaminophen dos age in humans without hepatic injury. Hepatology 1999; 29: 451-63.
-
(1999)
Hepatology
, vol.29
, pp. 451-463
-
-
Shayiq, R.M.1
Roberts, D.W.2
Rothstein, K.3
-
14
-
-
0028149489
-
Association of acetaminophen hepatotoxicity with fasting and ethanol use
-
Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994; 272: 1845-50.
-
(1994)
JAMA
, vol.272
, pp. 1845-1850
-
-
Whitcomb, D.C.1
Block, G.D.2
-
15
-
-
0030639567
-
Acetaminophen-induced hepatotoxicity: Predisposing factors and treatments
-
Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: Predisposing factors and treatments. Adv Intern Med 1997; 42: 453-83.
-
(1997)
Adv Intern Med
, vol.42
, pp. 453-483
-
-
Makin, A.J.1
Williams, R.2
-
16
-
-
33644858997
-
Elevated bilirubin may cause false positive acetaminophen levels in hepatitis patients
-
and the Acute Liver Failure Study Group
-
Polson J, Orsulak PJ, Wians F et al. and the Acute Liver Failure Study Group. Elevated bilirubin may cause false positive acetaminophen levels in hepatitis patients. Hepatology 2004; 40: 496A.
-
(2004)
Hepatology
, vol.40
-
-
Polson, J.1
Orsulak, P.J.2
Wians, F.3
-
17
-
-
0042008030
-
Changing patterns of causation and the use of transplantation in the United Kingdom
-
Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003; 23: 227-37.
-
(2003)
Semin Liver Dis
, vol.23
, pp. 227-237
-
-
Bernal, W.1
-
18
-
-
0035912582
-
Effects of legislation restricting packsizes of paracetamol and salicylate poisoning in the United Kingdom before and after study of long-term effects on poisoning
-
Hawton K, Townsend E, Deeks J et al. Effects of legislation restricting packsizes of paracetamol and salicylate poisoning in the United Kingdom before and after study of long-term effects on poisoning. BMJ 2001; 322: 1203-07.
-
(2001)
BMJ
, vol.322
, pp. 1203-1207
-
-
Hawton, K.1
Townsend, E.2
Deeks, J.3
-
19
-
-
0035986735
-
Paracetamol pack size restriction: The impact on paracetamol poisoning and over-the-counter supply of paracetamol, aspirin and ibuprofen
-
Sheen C, Dillon J, Bateman D et al. Paracetamol pack size restriction: the impact on paracetamol poisoning and over-the-counter supply of paracetamol, aspirin and ibuprofen. Pharmacoepidemiol Drug Saf 2002; 11: 329-31.
-
(2002)
Pharmacoepidemiol Drug Saf
, vol.11
, pp. 329-331
-
-
Sheen, C.1
Dillon, J.2
Bateman, D.3
-
20
-
-
19044371607
-
FDA fails to reduce accessibility of paracetamol despite 450 deaths a year
-
Moynihan R. FDA fails to reduce accessibility of paracetamol despite 450 deaths a year. BMJ 2002; 3325: 678.
-
(2002)
BMJ
, vol.3325
, pp. 678
-
-
Moynihan, R.1
|